Chemistry Reference
In-Depth Information
8. Imai, K., Matsuyama, S., Miyake, S., Suga, K., and Nakachi, K., Natural cytotoxic
activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up
study of a general population.
Lancet
, 356, 1795-1799, 2000.
9. Takeda, K., and Okumura, K., Effects of a fermented milk drink containing
Lactobacillus
casei
strain Shirota on the human NK-cell activity.
J. Nutr.,
137, 791-793, 2007.
10. Morimoto, K., Takeshita, T., Nanno, M., Tokutome, N., and Nakayama, K., Modulation
of natural killer cell activity by supplementation of fermented milk containing
Lactobacillus casei
in habitual smokers.
Prev. Med.,
40, 589-594, 2005.
11. Kusaka, Y., Kondou, H., and Morimoto, K., Healthy lifestyles and are associated with
higher natural killer activity.
Prev. Med.,
21, 602-615, 1992.
12. Ivory, K., Chambers, S.J., Pin, C., Prieto, E., Argués, J.L., and Nicoletti C., Oral delivery
of
Lactobacillus casei
Shirota modifies allergen-induced immune responses in allergic
rhinitis.
Clin. Exp. Allergy
, 38, 1282-1289, 2008.
13. Tamura, M., Shikina, T., Morihana, T., Hayama, M., Kajimoto, O., Sakamoto, A.,
Kajimoto, Y., Watanabe, O., Nonaka, C., Shida, K., and Nanno, M., Effects of probiot-
ics on allergic rhinitis induced by Japanese cedar pollen: Randomized double-blind,
placebo-controlled clinical trial.
Int. Arch. Allergy Immunol
, 143, 75-82, 2007.
14. Aso, Y., Akaza, H., and the BLP study group, Prophylactic effect of a
Lactobacillus casei
preparation on the recurrence of superficial bladder cancer
. Urol. Int.,
49, 125-129, 1992.
15. Aso, Y., Akaza, H., Tsukamoto, T., Imai, K., Naito, S., and the BLP study group,
Prevention effect of a
Lactobacillus casei
preparation on the recurrence of superficial
bladder cancer in a double-blind trial.
Eur. Urol.
, 27, 104-109, 1995.
16. Ohashi, Y., Nakai, S., Tsukamoto, T., Masunori, N., Akaza, H., Miyanaga, N., Kitamura,
T., Kawabe, K., Kotake, T., Kuroda, M., Naito, S., Koga, H., Saito, Y., Nomata, K.,
Kitagawa, M., and Aso, Y., Habitual intake of lactic acid bacteria and risk reduction of
bladder cancer.
Urol. Int.
, 68, 273-280, 2002.
17. Ishikawa, H., Akedo, I., Otani, T., Suzuki, T., Nakamura, T., Takeyama, I., Ishiguro,
S., Miyaoka, E., Sobue, T., and Kakizoe, T., Randomized trial of dietary fiber and
Lactobacillus casei
administration for prevention of colorectal tumors.
Int. J. Cancer
,
116, 762-767, 2005.
18. Barrett, J.S., Canale, K.E.K., Gearry, R.B., Irving, P.M., and Gibson, P.R., Probiotic
effects on intestinal fermentation patterns in patients with irritable bowel syndrome.
World J. Gastroenterol
., 14, 5020-5024, 2008.
19. Lin, H.C., Small intestinal bacterial overgrowth: A framework for understanding irri-
table bowel syndrome.
JAMA
, 292, 852-858, 2004.
20. Candy, D.C.A., Densham, L., Lamont, L.S., Greig, M., Lewis, J., Bennett, H., and
Griffiths, M., Effect of administration of
Lactobacillus casei
Shirota on sodium bal-
ance in an infant with short bowel syndrome.
J. Pediatr. Gastroenterol. Nutr
., 32, 506-
508, 2001.
21. Matsuzaki, T., Saito, M., Usuku, K., Nose, H., Izumo, S., Arimura, K., and Osame, M.,
A prospective uncontrolled trial of fermented milk drink containing viable
Lactobacillus
casei
strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic
paraparesis.
J. Neurol. Sci
., 237, 75-81, 2005.
22. Nakagawa, M., Izumo, S., Ijichi, S., Kubota, H., Arimura, K., Kawabata, M., and Osame,
M., HTLV-1-associated myelopathy: Analysis of 213 patients based on clinical features
and laboratory findings.
J. Neurovirol
., 1, 50-61, 1995.
